Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Patient Education and Counseling
|
April 8, 2022
Experience and outcome: Walking in the shoes of patients' loved ones
Andrew Alabd, Andre Alabd
Human Pathology
|
November 21, 2021
High-intensity focused ultrasound for the treatment of prostate cancer: assessing location of failure after focal therapy in prostate cancer and review of histological characteristics and clinicopathologic correlates after treatment-a 5-year experience
Katrina Collins, Eric Brocken, Clinton D Bahler, et al.
Annals of Surgical Oncology
|
September 24, 2020
Elucidating the Causes of Improved Survival in Clinical Trials of Randomized Adjuvant Pancreatic Ductal Adenocarcinoma (PDAC)
Andre Alabd, Andrew Alabd, Oloruntoba Bolaji, et al.
Cureus
|
March 28, 2022
New Model for Osteoporosis Risk Screening Using Emergency Department Visits
Andrew Alabd, Andre Alabd, Matthew Miller, et al.
The Journal of Surgical Research
|
January 16, 2021
Pancreatic Cancer-Associated Diabetes is Clinically Distinguishable From Conventional Diabetes
Bo Hyung Yoon, Su Mae Ang, Andre Alabd, et al.
Geriatric Orthopaedic Surgery & Rehabilitation
|
August 13, 2020
Risk Factors of Recurrent Falls Among Older Adults Admitted to the Trauma Surgery Department
William Curran-Groome, Gary Klein, Stanton B Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2023
Primary Retroperitoneal Lymph Node Dissection for Stage II Seminoma: Is Surgery the New Path Forward?
Isamu Tachibana, Andre Alabd, Yan Tong, et al.
Oncotarget
|
June 10, 2025
Exceptional responders to immunotherapy in pancreatic cancer: A multi-institutional case series of a rare occurrence
Kavin Sugumar, Andrew Alabd, Andre Alabd, et al.
Urologic Oncology
|
August 5, 2023
Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for seminoma: Limitations of surgical intervention after first-line chemotherapy
Isamu Tachibana, Andre Alabd, Rumeal D Whaley, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Patient Education and Counseling
|
April 8, 2022
Experience and outcome: Walking in the shoes of patients' loved ones
Andrew Alabd, Andre Alabd
Human Pathology
|
November 21, 2021
High-intensity focused ultrasound for the treatment of prostate cancer: assessing location of failure after focal therapy in prostate cancer and review of histological characteristics and clinicopathologic correlates after treatment-a 5-year experience
Katrina Collins, Eric Brocken, Clinton D Bahler, et al.
Annals of Surgical Oncology
|
September 24, 2020
Elucidating the Causes of Improved Survival in Clinical Trials of Randomized Adjuvant Pancreatic Ductal Adenocarcinoma (PDAC)
Andre Alabd, Andrew Alabd, Oloruntoba Bolaji, et al.
Cureus
|
March 28, 2022
New Model for Osteoporosis Risk Screening Using Emergency Department Visits
Andrew Alabd, Andre Alabd, Matthew Miller, et al.
The Journal of Surgical Research
|
January 16, 2021
Pancreatic Cancer-Associated Diabetes is Clinically Distinguishable From Conventional Diabetes
Bo Hyung Yoon, Su Mae Ang, Andre Alabd, et al.
Geriatric Orthopaedic Surgery & Rehabilitation
|
August 13, 2020
Risk Factors of Recurrent Falls Among Older Adults Admitted to the Trauma Surgery Department
William Curran-Groome, Gary Klein, Stanton B Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2023
Primary Retroperitoneal Lymph Node Dissection for Stage II Seminoma: Is Surgery the New Path Forward?
Isamu Tachibana, Andre Alabd, Yan Tong, et al.
Oncotarget
|
June 10, 2025
Exceptional responders to immunotherapy in pancreatic cancer: A multi-institutional case series of a rare occurrence
Kavin Sugumar, Andrew Alabd, Andre Alabd, et al.
Urologic Oncology
|
August 5, 2023
Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for seminoma: Limitations of surgical intervention after first-line chemotherapy
Isamu Tachibana, Andre Alabd, Rumeal D Whaley, et al.
Page
of 1